| abstract |
Compounds of Formula I: (See Formula) in which X, Y, Z, R1, R2, R3, R4 are as defined herein, their pharmaceutically acceptable salts are described as useful for the treatment of associated cognitive deficits. with schizophrenia or other psychiatric, neurodegenerative and / or neurological disorders in mammals, including humans. |